Common name
3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
IUPAC name
3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
SMILES
C(Oc1c(cncc1)C)C(F)(F)F
Common name
3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
IUPAC name
3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
SMILES
C(Oc1c(cncc1)C)C(F)(F)F
INCHI
InChI=1S/C8H8F3NO/c1-6-4-12-3-2-7(6)13-5-8(9,10)11/h2-4H,5H2,1H3
FORMULA
C8H8F3NO
Common name
3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
IUPAC name
3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
Molecular weight
191.150
clogP
2.671
clogS
-2.992
Frequency
0.0003
HBond Acceptor
2
HBond Donor
0
Total PolarSurface Area
22.12
Number of Rings
1
Rotatable Bond
3
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00323 | Lansoprazole |
|
Enzyme Inhibitors; Anti-Ulcer Agents; Proton Pump Inhibitors; Anti-Infective Agents; Alimentary Tract and Metabolism; Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord); Drugs for Acid Related Disorders; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; | For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use. |
1 ,
1
